Results 21 to 30 of about 10,856 (235)

Treatment of pretibial myxedema with intralesional immunomodulating therapy

open access: goldTherapeutics and Clinical Risk Management, 2017
Objective Local immune regulation therapy has been one of the therapeutic methods used for the treatment of autoimmune thyroid disease in patients with pretibial myxedema (PTM).
Ziwei Ren   +6 more
semanticscholar   +5 more sources

Periorbital Myxedema [PDF]

open access: hybridJournal of Osteopathic Medicine, 2016
Jimmy Tam Huy, Pham   +1 more
openaire   +3 more sources

Subclinical Hypothyroidism Presenting as Myxedema Coma: Case Report and Literature Review

open access: yesCureus, 2022
Myxedema coma is a medical emergency with a high mortality rate. Patients with hypothyroidism may develop myxedema coma if left untreated, although quite rare nowadays owing to regular TSH (thyroid stimulating hormone) monitoring.
Tsering Dolkar   +4 more
semanticscholar   +1 more source

A Rare Case of Myxedema Coma with Neuroleptic Malignant Syndrome (NMS) [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2015
Myxedema coma or hypothyroid crisis is an endocrine emergency and needs ICU management. Neuroleptic malignant syndrome (NMS) is another medical emergency which needs high degree of clinical suspicion else mortality can be high. There is a paradox in co
Siddharth Dixit   +2 more
doaj   +1 more source

A case of fatal myxedema coma with electrocardiogram Osborne J-wave in a patient initially diagnosed with hypothyroidism.

open access: yesEndocrine journal, 2022
Myxedema coma is a life-threatening endocrine emergency with a high mortality rate resulting from severe insufficiency of thyroid hormones. Intravenous levothyroxine replacement is considered the standard therapy for myxedema coma in many countries.
M. Kaneko, K. Ohara, Hisaharu Shikata
semanticscholar   +1 more source

Myxedema Psychosis in a Patient With Undiagnosed Hashimoto Thyroiditis

open access: hybridThe Journal of the American Osteopathic Association, 2017
Matthew M. Mavroson   +2 more
openalex   +2 more sources

Periorbital myxedema treated with intralesional hyaluronidase

open access: yesAmerican Journal of Ophthalmology Case Reports, 2020
Purpose: Periorbital myxedema is one the most challenging symptoms for patients with Graves' eye disease (GED). The treatment of this condition is complex and often unsatisfactory.
Aleksandra L. Lindgren   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy